Progyny, Inc. (NASDAQ:PGNY) Shares Acquired by International Assets Investment Management LLC

International Assets Investment Management LLC grew its position in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 1,576.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,565,118 shares of the company's stock after purchasing an additional 2,412,068 shares during the quarter. International Assets Investment Management LLC owned approximately 2.84% of Progyny worth $42,991,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Quarry LP grew its holdings in shares of Progyny by 1,900.0% during the second quarter. Quarry LP now owns 880 shares of the company's stock worth $25,000 after purchasing an additional 836 shares during the last quarter. TFC Financial Management Inc. purchased a new position in shares of Progyny in the 1st quarter valued at about $42,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Progyny during the second quarter worth $44,000. Cambridge Trust Co. acquired a new stake in Progyny in the first quarter valued at $95,000. Finally, Natixis Investment Managers International purchased a new position in shares of Progyny in the first quarter valued at $117,000. 94.93% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

PGNY has been the topic of a number of analyst reports. Leerink Partnrs cut Progyny from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 7th. Canaccord Genuity Group dropped their price objective on Progyny from $24.00 to $18.00 and set a "hold" rating for the company in a research report on Friday, September 20th. BTIG Research lowered shares of Progyny from a "buy" rating to a "neutral" rating in a report on Wednesday, August 7th. JPMorgan Chase & Co. decreased their price target on shares of Progyny from $31.00 to $22.00 and set an "overweight" rating on the stock in a research note on Thursday, September 19th. Finally, JMP Securities downgraded shares of Progyny from an "outperform" rating to a "market perform" rating in a research note on Thursday, September 19th. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, Progyny currently has an average rating of "Hold" and a consensus price target of $27.73.

Progyny Stock Up 2.5 %

Shares of PGNY stock traded up $0.38 on Monday, reaching $15.83. 3,173,495 shares of the stock were exchanged, compared to its average volume of 1,380,833. The stock has a market cap of $1.43 billion, a P/E ratio of 25.21, a price-to-earnings-growth ratio of 1.46 and a beta of 1.43. The firm has a 50 day moving average of $19.34 and a two-hundred day moving average of $25.07. Progyny, Inc. has a 1-year low of $13.93 and a 1-year high of $42.08.

Progyny (NASDAQ:PGNY - Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.17 EPS for the quarter, hitting the consensus estimate of $0.17. Progyny had a return on equity of 11.97% and a net margin of 5.54%. The company had revenue of $304.09 million during the quarter, compared to analyst estimates of $305.32 million. During the same period in the prior year, the firm posted $0.15 earnings per share. The firm's revenue was up 8.8% on a year-over-year basis. On average, equities research analysts predict that Progyny, Inc. will post 0.64 EPS for the current fiscal year.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.